Ascenda Partners with Cardless to Transform Co-Brand Landscape and Enable New Loyalty Opportunities NEW YORK, Dec. 12, 2024 /PRNewswire/ — Ascenda, the industry leader in… CISION PRNewswireDecember 12, 2024
Press ReleasePorton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S. CHONGQING, China, Dec. 12, 2024 /PRNewswire/ — Recently, Porton Pharma Solutions Ltd. ("Porton")… CISION PRNewswireDecember 12, 2024
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection – A Novel Antiplatelet Therapy SHANGHAI, Dec. 12, 2024 /PRNewswire/ — CureGene Pharmaceutical ("CureGene"), a biotechnology company… CISION PRNewswireDecember 12, 2024
Press ReleaseSK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials… CISION PRNewswireDecember 12, 2024
Press ReleaseA New Era of Customer-Centricity with IFF Pharma Solutions' AnswerCenter Platform Web-based customer platform provides answers at customers’ fingertips NEW YORK, Dec. 12,… CISION PRNewswireDecember 12, 2024
Xinhua Silk Road: Exploring charm of intangible cultural heritage in Minhang District of Shanghai BEIJING, Dec. 12, 2024 /PRNewswire/ — The city of Shanghai is a first… CISION PRNewswireDecember 12, 2024
Xinhua Silk Road: Pien Tze Huang boosts TCM globalization BEIJING, Dec. 12, 2024 /PRNewswire/ — Zhangzhou Pien Tze Huang Pharmaceutical Co.,… CISION PRNewswireDecember 12, 2024
China Matters' Feature: How History Uncovers the Culture HANGZHOU, China, Dec. 12, 2024 /PRNewswire/ — In the heart of Hangzhou, China,… CISION PRNewswireDecember 12, 2024
